Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism — Stella

Home/Autoimmune Encephalitis/

View on ClinicalTrials.gov

Recruiting

Back to Autoimmune Encephalitis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

Hospital Pitie Salpetriere, Paris

Key details

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment target

~56 participants

Started

May 2024

Primary completion

April 2026

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.